Well the technicals of the conference call left a lot to be

New Post Public Reply Private Reply Replies (4) Message Board
pacsurg21
584
Well the technicals of the conference call left a lot to be desired today. I actually enjoyed Rich's update and thought that he did a nice job walking us through the process step by step on what they did to create the vaccine. I took away a positive and very energized feeling from the call...and then I looked at the stock price. Wow...it seems that perhaps his description was not well understood by everyone.

Here's my best description of my takeaway as I took copious notes:
1. They don't have to do their human late stage study with 30,000 people, only less than 10,000 will likely be the case = This will speed up the process substantially!
2. ~15 days away from IND package being submitted...once the results are finalized they can immediately submit IND to FDA.
3. Improved logistics (considerably versus other vaccines) = Room Temp Vaccine, completely mixed with adjuvant and can be made and kept in very large quantities.
4. Transgenic Mouse Study = finds out if the trigger in NGIOs "complete vaccine" will incrementally do better than the others that are out there at the DR-4, which may be key for showing improvement in efficacy to that of the other available vaccines. (I'd like clarity on this point, so maybe someone can ask Rich to elaborate, but it did seem very positive and would allow NGIO to achieve superiority)
5. If the "complete vaccine" is a complete fail, it will at very least be the leading booster the world has seen for all of these current vaccines...This seems like the best news in the entire call.

*In my opinion a failure could actually be more profitable for GNBT/NGIO than a success as it would be required to be more widely used and it may be useful as an overlay for all other brands of vaccine. Everyone will flock to license this overlay as it will increase their vaccine's effectiveness especially J&J/AstraZeneca.

China Update:
Sinopharm is partnering with them and will license 100% of NGIO's product platform...please let that one sink in
$50,000,000 payment for working with them on vaccine getting green-light from them. $5,000,000 is delayed due to int'l transfer issues with dealing with a communist country, but the transfer is coming. $1,000,000 payment already received. This means that according to earlier conference calls that the NGIO complete vaccine in China Testing has already been a success...they likely cannot talk about this yet, but given that they are moving the project forward this can be safely assumed.

China is a much larger opportunity than in the USA for the vaccine product. Please understand this. It is hard to not have regional bias as this is what we can understand, but working with China will do two things.
1. Vastly speed up the regulatory process, ex. Communist countries are better at pooling resources and getting things done quickly than other countries (evidenced by how quickly they built their first COVID-19 hospital from the ground up)
2. The amount of money to be made throughout all of the licensing is astounding and will boost NGIO to achieve far reaching success. It will get easier to gain transfers of large sums of funds over time as well, so the issues we are seeing now will mostly subside once they establish consistent transfers.

China is not the country that it used to be in terms of technology and biotech. The companies that are leading there in 5-10 years will lead the world in technology (IMO). They already benefit from having mfg there for nearly all the world's medical devices and the Germans have mostly moved MFG there on the quality German-built machines. Like Elon Musk says, the value of the machine that builds the machine/thing can has a greater impact overall. This is now happening in Pharma. It is great for GNBT and NGIO that they are there now.

Overall takeaway: From a capitalist perspective, I would like to see that NGIO MFGS both a vaccine and a separate booster, and I believe that the booster will be a more successful product for NGIO. NGIO will have the freedom to introduce this as a new product and actually charge more for it as it will not fall into the same contracts as the vaccine.

I agree it is disappointing that the technicals did not work better as an update of NGIO IPO would have been very nice. I was surprised that the people who did get through did not ask that question. Overall the information is positive folks...





Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 121

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 123

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 135

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 88

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 90

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading

Top 5 Most Recently Viewed Articles

Protecting Your Rights as a Match Group, Inc. Investor

Updated Category News Views 82

Understanding Your Legal Rights as a Match Group, Inc. Investor Investors in Match Group, Inc. have been notified about an important class action securities lawsuit initiated by Levi & Korsinsky, LLP. This legal action aims to safeguard the interests of investors who might have suffered financial losses due to alleged securities fraud. What is the Class Action Lawsuit...

Continue Reading
Experience Cutting-Edge Communication Solutions at MWC25

Updated Category News Views 449

Hytera Communications at MWC25 Hytera Communications, a leading provider of professional communications technologies and solutions, is excited to announce its participation in the upcoming Mobile World Congress 2025 (MWC25). This prestigious event will take place at the Fira Gran Via in Barcelona. Hytera is eager to showcase its innovative portfolio of mission-critical...

Continue Reading
Home Chef's New Partnership with Giada: What's the Scoop?

Updated Category News Views 241

Home Chef's Flavorful Collaboration This takes me back, ya know? Reminds me of when brands tried to jazz things up with culinary pros. Home Chef, that name's been buzzing around the meal kit world, right? They’ve teamed up with culinary superstar Giada De Laurentiis—an Emmy winner, no less—for an exclusive eight-week menu packed with Italian flair. Like, who...

Continue Reading
Angeles Equity Partners Welcomes Chetan Bhandari as Leader

Updated Category News Views 315

Angeles Equity Partners Enhances Leadership with New Appointment Angeles Equity Partners, a well-regarded private investment firm, announces the addition of Chetan Bhandari as the new Head of Capital Markets within the Angeles Operations Group. Bhandari enters this role equipped with over 30 years of rich experience in the financial sector. His expertise spans advising...

Continue Reading
Investors Alert: Join Ready Capital Corporation Class Action

Updated Category News Views 246

Understanding the Class Action Opportunity for Investors The landscape for investors can often seem daunting, particularly with securities fraud cases disrupting the financial market's integrity. One prominent case currently unfolding involves Ready Capital Corporation, traded under NYSE: RC. A class action lawsuit is underway, which gives affected investors a chance to...

Continue Reading